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Abstract
Vibrio cholerae is a facultative human pathogen responsible for the cholera disease 
which infects millions of people worldwide each year. V. cholerae is a natural inhabit-
ant of aquatic environments and the infection usually occurs after ingestion of 
contaminated water or food. The virulence factors of V. cholerae have been exten-
sively studied in the last decades and include the cholera toxin and the coregulated 
pilus. Most of the virulence factors of V. cholerae belong to the secretome, which 
corresponds to all the molecules secreted in the extracellular environment such as 
proteins, exopolysaccharides, extracellular DNA or membrane vesicles. In this chap-
ter, we review the current knowledge of the secretome of V. cholerae and its role in 
virulence, colonization and resistance. In the first section, we focus on the proteins 
secreted through conventional secretion systems. The second and third sections 
emphasize on the membrane vesicles and on the secretome associated with biofilms.
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1. Introduction
Vibrio cholerae is a Gram-negative bacterium responsible for the cholera disease, 
which infects millions of people per year worldwide. In the environment, V. cholerae 
is a common inhabitant of aquatic ecosystems. Over more than 200 serotypes of 
V. cholerae have been described, but only two are responsible of the pandemics, i.e. 
O1 and O139 serotypes. The O1 serotype is divided in two biotypes, classical and El 
Tor. The V. cholerae O1 El Tor is responsible for the ongoing 7th pandemic [1]. The 
infection usually begins with the ingestion of contaminated water or food. Once 
inside the human host, V. cholerae colonizes the small intestine where biofilm-like 
structures have been observed [2]. The colonization and virulence inside the host 
are highly correlated with the secretion of a panel of proteins, including the cholera 
toxin (CT). The toxin is responsible for the misfunction of the calcium channel of 
the host epithelial cells, leading to the cholera characteristic massive loss of water 
and the diarrhea [3]. This review aims to focus on the secretome of V. cholerae and 
the secretion systems used by this bacterium to colonize the human host, compete 
with other bacteria, and survive in the environment.
2. Secretion systems
V. cholerae possesses as many as five multicomponent secretion systems, allowing 
secretion or translocation of a broad range of molecules into the extracellular milieu 
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or directly into the neighbouring cells. These molecules are essential for niche 
competition in the environment and for persistence in the host.
2.1 Type II secretion system for virulence and environmental fitness
The type II secretion system (T2SS) shares many structural characteristics with 
the type IV pilus (T4P) and is conserved among Gram-negative bacteria for delivery 
of colonization and virulence factors in the extracellular milieu [4, 5]. In V. cholerae, it 
is used in the aquatic environment and in the human host to secrete exoproteins from 
the periplasm to the extracellular milieu or to anchor the bacteria to the host cells 
[4, 6]. The loss of T2SS altered growth, biofilm formation, antimicrobial resistance, 
and cell envelope integrity, suggesting that the T2SS has an essential role in this 
bacterium, which makes it a suitable target for therapeutic development [7–9]. The 
T2SS genes are referred to as extracellular protein secretion (eps) [7]. Hydrolyzation 
of ATP is required to provide energy for secretion [5]. The T2SS is anchored in both 
bacterial membranes and is distributed all over the bacterial surface [10, 11].
The growth defect of mutants lacking essential components or regulators of the 
T2SS shows that it is a vital component for V. cholerae, mostly since all the proteins 
secreted by the T2SS seem to act together to facilitate V. cholerae colonization and 
survival in ecological niches or in the human host. Majority of experiments occur in 
controlled laboratory conditions which do not represent the complexity of the intes-
tinal nor the marine niches. These conditions might influence the type of proteins 
that are secreted by the bacteria, as seen in the Sikora et al. study where the CT has 
not been detected in the supernatant while it is a known T2SS secreted protein [6].
2.1.1 Structure and secretion through the T2SS
The structural components [5] and secreted proteins [4] of the T2SS have 
recently been the object for reviews. Briefly, the T2SS assembles in 4 complexes; 
(i) the secretin, a pore located in the outer membrane, (ii) the inner membrane 
anchoring platform, (iii) the intracytoplasmic ATPase complex and (iv) the pseu-
dopilus. Even though the exact sequence of biogenesis is still unknown, a general 
pathway of assembly has been suggested.
The targeted proteins with signal peptides are firstly translocated to the peri-
plasm by Sec or Tat, where they are assembled to acquire a secretion competent 
conformation [12, 13]. Then, it has been proposed that they bind to the pseudopilin 
trimeric tip and to the inner membrane platform. This interaction activates the 
ATPase hydrolysis activity, thus the pseudopilus elongation by addition of pseudo-
pilin subunits and leads to the thrust of the secreted protein through the secretin 
channel as a piston [5]. It has been proposed that the signals for T2SS transportation 
are dependent on the protein conformation on the N-terminal signal peptides, but 
they have not been clearly identified yet [14].
2.1.2 Genes and regulation
The T2SS apparatus is composed of a dozen types of proteins, which are 
encoded on the eps operon (epsC to epsN), plus epsAB and the vcpD (pilD)  
genes in V. cholerae [7, 10]. Few studies have concentrated on the regulation of 
the T2SS in V. cholerae. Under laboratory conditions, the T2SS is constitutively 
expressed in V. cholerae following the growth rate of the bacteria with a higher 
expression at 25°C than at 37°C [15]. In addition, studies on the T2SS regulation 
suggest that several major regulatory pathways, including the quorum sensing, 
the c-di-GMP, the σE envelope stress response, might be involved [15, 16]. Finally, 
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as more than 20 extracellular proteins with important activities throughout the 
infection are secreted through the T2SS [6], this system must be tightly controlled 
over time to allow their synchronized secretion. Therefore, the expression of the 
cargo proteins is regulated by a panoply of regulators.
2.1.3 Secreted proteins
In V. cholerae, the T2SS ensures the transportation of more than 20 proteins with 
extracellular activities such as enzymes, toxins, virulence and colonization effec-
tors [6]. The T2SS is essential for survival in the aquatic environment and to infect 
the human gut. An essential process to colonize both environments is the ability to 
adhere to abiotic and biotic surfaces such as copepods and zooplankton exoskele-
tons and epithelial cells, respectively [17–19]. The surface-exposed GlcNAc binding 
protein (GbpA - VCA0811) is secreted by the T2SS and is an adhesion factor used by 
V. cholerae to bind chitinous surfaces, intestinal epithelial cells and mucin [18–21]. 
Chitin is the second most abundant polymer in nature and consists on N-acetyl-
D-glucosamine (GlcNAc) monomers linked in β-1,4 and the main component of 
copepods and zooplankton exoskeleton [22]. Attachment to marine crustacea and 
zooplankton is an advantage for nutrients acquisition, survival and dispersion 
in aquatic environment. GlcNAc-containing glycoconjugates are often beared by 
some glycoproteins at the surface of the intestinal epithelial cells and might insure 
adhesion to the epithelial cells [17, 23, 24]. GbpA possesses 4 domains, the 1 and 4 
being the most important for chitin binding, while only the 1 is needed for mucin 
binding [18]. As a secreted protein, GbpA must be able to interact with V. cholerae to 
allow its adhesion to the substrate. This function is assumed by the domains 3 and 4 
of GbpA, that bind to the bacterial surface [18]. GbpA is regulated by the quorum 
sensing and produced at low cell density [25]. At high cell density, HA/P and PrtV 
digest GbpA to allow cell detachment and propagation [25, 26]. Also, higher tem-
peratures increase the production of GbpA, promoting cell adhesion [27]. GbpA 
induces mucin secretion by intestinal epithelium, and mucin increases expression 
of GbpA [21]. Studies also determined that GbpA can induce necrosis of intestinal 
cells by increasing their membrane permeability [28]. Recently, a chitin cleavage 
activity under copper saturation has been described for GbpA and would therefore 
make it a lytic polysaccharide monooxygenase, a metalloenzyme copper-dependant 
capable of polysaccharide cleavage by oxidation [29]. Taken together, these findings 
suggest that GbpA is not only an early adhesion factor but might also have a more 
important role in pathogenesis.
In the aquatic environment, after binding to zooplankton, copepods and insect 
egg masses, V. cholerae can use chitin as source of carbon and nitrogen [14, 30]. To 
do so, V. cholerae secretes at least 2 chitinases: ChiA-1 and ChiA-2. The chitinase-1 
(ChiA-1 - VC1952) and 2 (ChiA-2 – VC0027) are secreted by the T2SS and syner-
gistically hydrolyzes the β1,4 bond between the GlcNAc monomers in the extracel-
lular milieu [6, 14, 31]. The expression and activity of V. cholerae chitinases are 
influenced by environmental factors such as pH, salinity or temperature [32]. In the 
extracellular milieu, ChiA-1 expression is induced by chitin via the sensor kinase 
of the orphan two-component system ChiS [31]. In the intestine, the expression 
of the chitinases is constitutive and a role for ChiA-2 in mucin degradation and in 
virulence has been reported [33]. Besides ChiA-1 and ChiA-2, other proteins might 
have a role in chitin utilization including the VCA0140 gene that encodes for the 
spindolin-related protein, the VC0769 gene product and the chitin oligosaccharide 
deacetylase (COD - VC1280) [6, 31, 34]. All of them are secreted by the T2SS [6]. 




Besides chitin, collagen can also be used as carbon source by V. cholerae. Collagen 
is one of the most abundant components of host tissues and aquatic animals, and 
can therefore be found in aquatic environments in association with marine life and 
sedimentation of decomposing animals [35]. Its degradation provides a nitrogen 
source, giving a growth advantage to collagenases producing bacteria [35]. The 
collagenase (VchC - VC1650) is a metalloprotease that degrades type I collagen, 
providing another carbon source for V. cholerae [36]. VchC has been recognized as a 
T2SS dependant extracellular protein [36]. In other Vibrio species, collagenases are 
recognized as virulence factors as it facilitates their dispersion by degradation of the 
cellular basal lamina, but this role has not been attributed to VchC yet [36].
After the ingestion, V. cholerae navigates through the digestive tract, where it 
survives many physical and chemical barriers such as gastric acid, peristaltic move-
ment, bile, mucin and microbiota. In the small intestine, it crosses mucin using its 
flagellum and the mucinase complex, that includes the vibriolysin, a zinc dependant 
metalloprotease hemagglutinin/protease (HA/P - VCA0865) secreted via the T2SS as a 
free protease or in a cell associated form [26, 37]. The structure, regulation, secretion 
mechanism and functions of HA/P have been reviewed recently [37]. Briefly, HA/P 
is expressed when cell density is high or when there is nutrient limitation through the 
HapR and RpoS regulators [38, 39]. It is translated as an inactive protein and chaper-
ones ensure its inactive state inside the cytoplasm, then the secretion occurs in 2 steps; 
(i) HA/P is translocated via Sec into the periplasm, (ii) the T2SS exports the protease 
in the extracellular space where an autocatalytic event activates HA/P [37]. HA/P has 
multiple targets to facilitate spreading of Vibrio and increases its virulence [37]. V. 
cholerae gains access to the intestinal epithelial cells by degradation of the mucus layer, 
lactoferrin and fibronectin by HA/P in order to release toxic effectors into the epithe-
lial cells [26]. In addition, HA/P can cleave toxins such as CT and lactoferrin to activate 
or increase their activity [26, 40, 41] and disrupts tight junctions between intestinal 
epithelial cells by occludin cleavage [42]. HA/P participates in V. cholerae’s release into 
the stool by degradation of mucin to detach bacteria from epithelial cells [43].
A second important component of the mucinase complex is the neuramidase 
(VCNA - VC1784). The sialidase, or neuraminidase, is encoded on the pathogenicity 
island of every toxigenic V. cholerae strains and is secreted by the T2SS [44]. VCNA 
removes the sialic acid that hides the ganglioside GM1, which is the receptor of the 
CT, on the surface of epithelial cells [45]. It binds to sialic acid to modify it by its 
N-terminal lectin domain [46]. Multiple enzymes (VesA, HA/P, and VCNA) appear 
to work synergistically and with redundancy, ensuring access to the receptor and 
the activation of the toxin immediately after its secretion [6].
The CT (VC1456-57) is an AB5 toxin secreted by the T2SS in the intestinal 
lumen, which represents the main virulence factor of V. cholerae found in O1 and 
O139 strains [3, 47]. The subunits are individually translocated by Sec into the 
periplasm, and the assembled toxin is translocated to the extracellular milieu by the 
T2SS [7]. The toxin is secreted in an inactive form and must be cleaved by human 
or bacterial protease to be activated [40]. CT is composed of five B subunits linked 
in a ring shape that bind to the ganglioside membrane receptor GM1 on the api-
cal surface of intestinal epithelial cells [3]. CT is internalised and transits to the 
endoplasmic reticulum. The A subunit is heterodimeric with the A2 as the linker 
between B and A1 subunits, and A1 as a mono-ADP-rybosyltransferase [3]. A1 is 
released in the endoplasmic reticulum by disulfide isomerase and translocated to 
the cytosol where it activates the adenylate cyclase G protein by addition of an ADP. 
Thereby, the activated adenylate cyclase increases the intracellular levels of cyclic 
AMP, which in turn, activates the protein kinase A (PKA). Finally, PKA activates 
the chloride anion (Cl−) excretion by phosphorylation of the chloride channel, that 
leads to major water secretion by osmose [3]. ctxA and ctxB genes are organized as 
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an operon on the integrated CTXφ lysogenic phage [48]. The secretin complex of 
the T2SS is required by CTXφ to exit the bacteria, which makes the T2SS essential 
for virulence and horizontal transfer of CT [49]. CT is expressed when the cell den-
sity is low, inversely to HA/P, which is why it has been suggested that HA/P could 
cleave the remaining non-activated CT when the cell density rises [50].
Prior to GM1 binding, the CT must be processed by extracellular proteases to be 
activated. These proteases are therefore important for virulence and colonization. 
Besides their capacity to activate the toxin, they have a role in finding a substrate 
(modification of integrin) and nutrients, and in deactivating host defense mecha-
nisms. Among the T2SS secreted proteins, 3 serine proteases with 30% homology 
between them have been identified, the Vibrio extracellular serine proteases (VesA 
- VCA0803; VesB - VC1200; VesC - VC1649) [6]. All three proteins have a N-terminal 
protease domain [6, 51]. VesB has a similar structure and specificity to trypsin [51]. 
Mutation of vesABC allowed to identify that VesB is the main responsible of the 
proteolytic activity, while VesA and VesC are responsible of 20% of the total proteo-
lytic activity [6]. VesABC do not require bivalent ions for their enzymatic activity [6]. 
Under laboratory growth conditions, VesA, and in a lesser extend VesB and HA/P, acti-
vate the CT in the extracellular milieu [6, 40]. VesC induces a hemorrhagic response in 
rabbit ileal loop model, which might also reflect a role in virulence [52]. VesB and VesC 
are expressed at low cell density while VesA is expressed at high cell density [4].
Other virulence factors secreted by the T2SS have been identified in V. cholerae. The 
extracellular metalloprotease (PrtV) is a Zn-dependant metalloprotease [53, 54]. Its 
activity depends on several autocatalytic events occurring inside and outside the cell for 
activation [55]. PrtV uses two mechanisms of secretion, in association with membrane 
vesicles (MV) and via the T2SS [6, 56]. PrtV cleaves host proteins such as extracellular 
matrix and substrate proteins, inducing a change in host cell conformation leading to cell 
death [53]. In addition, PrtV is necessary for killing of Caenorhabditis elegans and protec-
tion against predators [57]. To do so, PrtV has many substrates such as, but not limited 
to, fibronectin, fibrinogen and plasminogen [53]. PrtV is composed of two domains 
usually known to allow protein-protein or protein-carbohydrates interactions [55, 58]. 
Thus, PrtV is important for the colonization of ecological niches and in pathogenesis.
The cytolytic toxin cytolysin/hemolysin A (VCC or HlyA - VCA0219), is 
secreted by the T2SS [6]. All V. cholerae strains produce VCC, an iron-dependant 
secondary toxin activated by cleavage [59]. VCC leads to cell death by vacuolization 
of the target cell, after production of anions channels in the membrane [60]. Since 
VCC leads to chloride efflux in intestinal cells, and subsequently to sodium and 
water by osmosis, it has been suggested that VCC is the major factor responsible of 
diarrhea in non-producing CT strains.
Leucine aminopeptidase (Lap - VCA0812) and aminopeptidase (LapX - VCA0813) 
are other secreted proteases using T2SS [6]. Lap is a zinc dependant metallo-exo-
peptidase that cleaves leucin in N-terminal position, while the role of LapX remains 
unknown [61]. Both Lap and LapX have no role in virulence in a C. elegans model [57]. 
While the TagA-related protein (Tarp - VCA0148), the unidentified VCA0583 and 
VCA0738 proteins, as well as the putative lipoprotein VC2298, have been recognized 
as T2SS secreted proteins, their role in V. cholerae is still unknown [6].
Finally, several proteins involved in biofilm formation and dissemination are 
also secreted by the T2SS in V. cholerae. Biofilm protects bacteria from antibiotics, 
immune system and poor environmental conditions, thus allows their survival 
in diversified range of ecological niches. Many components are secreted into the 
extracellular milieu to form the matrix. Among them, Biofilm associated protein 1 
(Bap1 - VC1888) and rugosity and biofilm structure modulator A (RbmA - VC0928) 
and C (RbmC - VC0930) are the matrix proteins and are secreted by the T2SS [9]. 
In addition, the DNase Xds, an exonuclease would also be secreted by the T2SS [62]. 
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Xds is expressed at the late stage of infection, can contribute to survival against 
neutrophiles NET traps, to acquisition of new DNA and dispersion of the biofilm 
[62, 63]. More details about the roles of the matrix proteins and nucleases in biofilm 
formation are presented in the Biofilms and Flagella section.
2.2 Type VI secretion system for competition and DNA acquisition
The type VI secretion system (T6SS) is a versatile syringe-like apparatus with 
homology to the phage T4 and produced by more than 25% Gram-negative bacteria 
that, upon contact with a target cell, punctures its cell wall, allowing translocation of 
toxic effectors directly into the neighboring cells [64, 65]. The cellular targets of these 
effectors are multiple; peptidoglycan, actin, cellular membrane, nucleic acids and 
immune system components, for instance [66]. As the target cells release their DNA 
into the extracellular milieu upon lysis, another function of the T6SS is to capture the 
extracellular DNA (eDNA) in order to acquire new features such as antibiotic resis-
tance factors and new effectors or immunity proteins [67]. Bacteria use this device as 
a competition effector to take over the environmental niche and a single bacterium 
can possess as much as 6 different types of T6SS [65]. In V. cholerae, the T6SS is as 
efficient at killing bacterial competitors as it is at delivering toxic effectors to eukary-
otic host cells, making it an important colonization and virulence factor [68].
2.2.1 Structure and secretion through the T6SS
The T6SS is anchored in the cell membrane and contains 4 distinct domains; (i) 
the membrane complex, (ii) the baseplate, (iii) the contractile sheath and (iv) the 
syringe. The current knowledge on the structure of the T6SS have been reviewed 
elsewhere [64].
Valine glycine rich proteins G 1, 2 and 3 (VgrG1-3) and a single proline-alanine-
alanine-arginine repeated motif protein (PAAR) form the tip of the syringe [69]. 
There are multiple PAAR proteins in V. cholerae’s genome but only one binds and 
folds in order to form a sharpened tip and it has been shown to be essential for an 
efficient secretion by the T6SS [69]. The PAAR proteins also have toxic effector 
functions. The syringe is a tube composed of multiple hexameric rings of hemoly-
sin-coregulated protein (Hcp) [70]. Almost simultaneously, the syringe is wrapped 
by the helical contractile sheath made of VipA and VipB [71] which polymerizes 
in an extended conformation. This high-energy conformation provides enough 
energy, upon contraction signal, to propel the Hcp syringe, the VgrG-PAAR tip and 
the associated effectors into the extracellular milieu or directly into a near target 
cell by contraction and rotation of VipB [71]. VipA would function as a chaperone 
for the VipB subunits [71]. The contracted arrangement of VipB would expose the 
ClpV binding sites on VipB, which are hidden in the extended conformation. ClpV 
is the ATPase responsible for recycling the sheath components that can be reused 
for further effectors translocation [72, 73]. Adaptor proteins are required to load the 
effectors on the tip of the syringe; however, they are not secreted by the T6SS [74].
2.2.2 Genes and regulation
In V. cholerae, the core genes are organized in a main cluster operon that includes 
vipAB, hsiF, vasA to vasM and clpV, on the small chromosome [68]. It contains most 
of the structural components of the T6SS, except for Hcp, in addition to the regula-
tor VasH and recycling protease ClpV. At least 2 auxiliary clusters (Hcp –1 and –2), 
harbouring Hcp, VgrGs, adaptor and effector/immunity proteins, are distributed 
in the genome [75]. Some strains, including pandemic strains, have an additional 
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auxiliary cluster (Aux –3) coding for a second PAAR protein and extra effector/
immunity module set [75]. Recently, two other auxiliary clusters, Aux –4, coding for 
the predicted Tse4, and Aux –5, coding for Hcp, a VgrG protein, an adaptor protein 
and effector/immunity module set, have been identified [75, 76]. While the genes 
from the main cluster are highly conserved, the auxiliary clusters, even from the 
pandemic strains harbouring the same effectors/immunity module sets, only share 
about 30 % homology between them [77].
The complexity of the apparatus and its organization require a fine regulation to 
insure its efficiency and recycling. The transcriptional regulation of the T6SS in V. 
cholerae is strain dependant [78, 79], complex and not entirely understood yet. As 
the environmental strains constitutively express the T6SS to control the surrounding 
bacterial populations and survive predators of the ecological niche, the pathogenic 
strains tightly regulate their T6SS [79, 80]. Quorum sensing, the chitin and bacterial 
competence pathways, osmolarity and other environmental conditions are involved 
in the regulation of the T6SS (for a more detailed review of the T6SS see: [64]).
2.2.3 Secreted proteins
As mentioned before, the T6SS apparatus carries toxic effectors directly into the 
target bacterial or eukaryotic cells. A single contraction event allows the transloca-
tion of many of these effectors at the same time into the target cell [69]. The cellular 
targets for these effectors are multiple; they go from peptidoglycan to cellular mem-
brane, actin and nucleic acids [64]. To protect themselves against the toxic effectors 
they produce, bacterial cells express immunity proteins, which brings the notion of 
strains compatibility (for more information see: [81]). The secreted effectors and 
structure components can be reused by recipient cells to form a new T6SS [82].
Hcp is one of the proteins transported by the T6SS into the target cell, in addi-
tion to be part of its structure by forming the inner tube and serving as a chaperone 
to the effector molecules [83]. Hcp is encoded by two different yet functional genes 
(VC1415; VCA0017) producing the same protein [68, 84]. Both genes must be 
knocked out to suppress the T6SS activity [68]. Hcp is co-expressed with HlyA, and 
its secretion was observed before the discovery of the T6SS [84].
Similarly to Hcp, the VgrG proteins (VC1416; VCA0018; VCA0123) are part of 
the T6SS structure and are secreted into the target cell upon contraction of the T6SS 
[68, 85]. VgrG-1 has an actin cross-linking activity in eukaryotic cells, thus prevent-
ing cytoskeleton reorganization and phagocytosis [86]. VgrG-2 is homologous to 
VgrG-1, but without a functional C-terminal effector domain [85]. Both appear to 
be essential for secretion of other T6SS components as a mutational inactivation of 
one of these gene makes the mutant unable to secrete any T6SS-dependant effectors 
[85]. Since its toxicity is exclusive to eukaryotic cells, no immunity coupled protein is 
required against VgrG-1. The VgrG-3 protein is known to be active against other bac-
teria by hydrolyzing peptidoglycan with its lysozyme-like domain, after a transloca-
tion to the periplasm [85, 87]. It might also have a muramidase activity, which could 
be useful in its aquatic niche to gain access to chitin or in infection to cross mucin 
[88]. TsiV3 (VCA0124) acts as the antitoxin for VgrG-3 by biding to it and prevents 
the degradation of the cell wall in the predator bacteria [87]. Thus, VgrG-3 might be 
important for infection by killing gut microbiota and by hydrolysing mucin.
The PAAR proteins (VCA0284; VCA0105), along with VgrGs, form the tip of the 
syringe of T6SS, bind the effectors and are therefore essential for T6SS effectors’ 
secretion. There are two proteins with a PAAR domain in V. cholerae’s genome with 
enzymatic activities that could be toxic for eukaryotic or prokaryotic cells, thus acting 
as effectors [69]. PAAR proteins are secreted by the T6SS by caping the tip of the 
syringe, the PAAR domain allowing the bond with the VgrG trimeric tip. As Hcp, VgrG 
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and PAAR proteins can bind and load effectors, the multiple effector translocation 
VgrGs (MERV) model has been proposed, suggesting that the T6SS spike (Hcp-VgrG-
PAAR) can deliver different cargo effectors at the same time into the targeted cell [69].
The cargo effector VasX (VCA0020) acts as a colicin and targets the inner 
bacterial membrane or eukaryotic membrane in which it is believed to form pores, 
increase permeability and lead to its disruption [89]. It is encoded downstream of 
Hcp-2 and VgrG-2 and is regulated by VasH [89]. Its immunity coupled protein is 
TsiV2 (VCA0021) [88]. The VasW (VCA0019) protein encoded right upstream 
VasX is an adaptor protein that plays a role in secretion of VasX and an accessory 
role to VasX bactericidal activity [90].
The type six effector Lipase (TseL - VC1418) is another cargo effector and its 
secretion depends on the presence of VgrG-3. It carries a phospholipase domain that 
is believed to cause damage to cell membranes in both eukaryotic and prokaryotic 
cells [88, 91]. Its immunity coupled protein is TsiV1 (VC1419).
The type six effector Hydrolase (TseH - VCA0285) is encoded next to the PAAR 
protein and its secretion is dependant of the T6SS [92]. It has been shown that TseH 
is able to degrade peptidoglycan, a main component of the bacterial cell wall, by 
hydrolysis and would therefore make it an important effector as for interbacterial 
competition. Its immunity coupled protein is the type six immunity hydrolase (TsiH 
- VCA0286), which prevents cell wall degradation.
Recently, another lipase, the Type VI lipase effector Vibrio (TleV1) has been 
discovered in environmental V. cholerae’s genome [75]. TleV1 has a toxic activity 
in bacteria, mainly in periplasm, by targeting phospholipids and destabilizing the 
cellular membrane. Two immunity coupled proteins are associated with TleV1, 
TliV1a and TliV1b (type VI lipase immunity Vibrio 1a and 1b), but only TliV1a has 
an effective neutralizing effect against TleV1.
It is most likely that, as genome analysis of more V. cholerae strains will occur, 
new effector/immunity modules will be identified as they can be transferred 
between strains by genetic transfer or acquisition of eDNA upon target cell lysis 
[67, 75, 76, 93]. All the pandemic strains encode the same effector/immunity 
module sets (TseL/TsiV1, VasX/TsiV2 and VgrG3/TsiV3, called AAA), as a result of 
intraspecific competition [93]. Some strains harbour immunity genes without the 
coupled effector that they acquired from gene transfer, named orphan immunity 
proteins, allowing their survival from multiple toxic effectors [80]. The modules 
found within strains may differ from each other, however, their diversity and their 
omnipresence testify of their value for virulence and competition of the niche.
2.3 Type I secretion system, a tool for auxiliary toxins secretion
The type I secretion system (T1SS) is used by Gram-negative bacteria to secrete, 
in a one-step process using ATP, proteins directly into the extracellular milieu.
2.3.1 Structure and secretion through the T1SS
The most studied T1SS is the hemolysin A associated T1SS (HlyA-T1SS) from 
E. coli and its general structure has been reviewed elsewhere [94]. Briefly, the T1SS 
are composed of 3 proteins encoded on the same operon, next to their associated 
secreted protein and activator; (i) an outer membrane protein (TolC), (ii) an ATP 
binding cassette (ABC) transporter in the inner membrane (HlyB), and (iii) a linker 
protein (HlyD) anchored in the inner membrane, linking the two other components.
The secreted proteins carry a C-terminal secretion signal sensed by the inner 
membrane proteins upon binding [95]. The porin TolC is then recruited to the 
complex, and the proteins pass through the HlyB and HlyD channel. The binding 
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of TolC to the inner membrane complex allows its opening and the secretion of the 
protein to the extracellular milieu, whereafter TolC leaves the complex [94]. As 
the inner membrane proteins bind to specific substrates, the TolC can be used by 
multiple T1SS within a cell [96]. The secreted proteins have a functional domain in 
N-terminal and are secreted shortly after their translation in their unfolded state. 
In V. cholerae, the T1SS structure is atypical and is composed of 4 components: the 
periplasmic linker RtxD, the outer membrane protein TolC, and 2 ATPases RtxB 
and RtxE, which most probably form heterodimers in the inner membrane instead 
of the conventional homodimer ATPase [97].
2.3.2 Genes and regulation
The rtx gene cluster is encoded near the CTXφ phage, but their regulation is not 
linked [98]. RtxA is secreted by its own unorthodox T1SS that requires two ABC 
transporters for the secretion [97]. The rtx locus is composed of 2 operons, the 
first one is left oriented and contains a conserved hypothetical gene VC1449, the 
activator (rtxC) and the toxin (rtxA). The second, right oriented, contains the ABC 
transporter (rtxB) and the fusion protein (rtxD) genes, plus the extra ABC trans-
porter rtxE. The tolC is encoded further. The RtxA toxin secretion is optimal during 
the exponential phase of growth but is inhibited in stationary phase [98].
2.3.3 Secreted proteins
The repeat in toxin (RTX) proteins are a class of proteins exclusively secreted by 
the T1SS [99]. They include the HlyA of E. coli (but not of V. cholerae – see T2SS) and 
RtxA and FrhA of V. cholerae. Briefly, these proteins contain glycine and aspartate-
rich sequence in C-terminal, before their T1SS secretion signal, and a functional 
domain originally associated with toxin activities. They require activation by the 
acetyl transferase activator encoded within the operon. The RTX region offers many 
Ca2+ binding sites. Once bound to the sites, the Ca2+ generates a sudden conformation 
change and formation of the secondary structure of the RTX protein. As the Ca2+ 
concentrations are low inside the cells, the RTX proteins keep their unfolded state 
until they reach the extracellular milieu, where the Ca2+ concentrations are higher.
One T1SS has been described in V. cholerae. It is associated to the RTX toxin 
(RtxA), a large toxin found in many V. cholerae strains, including O1 El tor, O139 
and non-O1/O139 strains, but not in the O1 classical strains that contain a deletion 
into the gene cluster [98, 100]. The omnipresence of RtxA toxin among currently 
circulating strains lets us think that it is an important virulence factor that could 
be responsible for the non-O1/O139 strains’ emergence [100]. RtxA leads to the 
depolarization of actin, by cross-linking the actin monomers into dimers, trimers or 
multimers, which causes rapid rounding of host cells [101–104].
Three other T1SS could be found in V. cholerae’s genome. The first one is associ-
ated to two putative RTX toxins with hemolytic activity (RtxL1 and RtxL2) that 
have been discovered in the genome of many V. cholerae strains [105]. They induce 
cell rounding and cytotoxicity and, unlike RtxA, also have a hemolytic activity. The 
locus has been identified but the secretion pathway has not, although all RTX pro-
teins are secreted through a T1SS, the RtxL associated T1SS is yet to be described. 
Another of the putative T1SS of V. cholerae is associated to another RTX-like toxin, 
the Flagellum-regulated hemagglutinin A (FrhA - VC1620) [106]. The decreased 
hemagglutination in non-motile V. cholerae mutant has led to the discovery of FrhA. 
FrhA contains a RTX-like domain and a T1SS signal and has a role in hemagglutina-
tion, adhesion to human host cells and chitin, thus in colonization and biofilm 
formation [107]. Its regulation is comprised in the four-step hierarchy regulation of 
Vibrios
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motility, which includes the regulation of several virulence factors. FrhA is encoded 
in a gene cluster harbouring components with homology to TolC (FrhC - VC1621) 
and HlyB (VC1628). However, no HlyD homolog has been found in the surrounding 
genes and the homology of VC1618 to HlyB is poor, as the ATP binding site, essen-
tial to the translocation process through the T1SS, is missing [106]. This secretion 
system is yet to be described. The retention module-containing protein (CraA - 
VCA0849) also contains a glycine rich module used as T1SS secretion signal, but its 
secretion system remains to be described [108]. CraA is an adhesin that has a role in 
early stage of biofilm formation by binding chitin. It has some homology to RtxA. In 
other Gram-negative bacteria, it serves as an adhesin on the bacterial surface.
2.4  Type III secretion system for colonization and injection of effectors into 
eukaryotic host cells
The Type III secretion system (T3SS) is a multicomponent device translocating 
various effectors directly into the neighbouring eukaryotic host cells and is found 
in many Vibrio species, including V. cholerae [109]. Many non O1/O139 strains, 
which can lead to severe diarrhea even though they do not produce the CT and toxin 
coregulated pilus (TCP), possess a T3SS [110, 111]. Unlike the pandemic strains, the 
diarrhea induced by non O1/O139 strains shows damages to the intestinal epithe-
lium [112]. The T3SS would in fact be essential for intestinal colonization and inva-
sive diarrhea in those strains. The T3SS is composed of a basal structure that shares 
similarities with the flagella, and a needle, connecting the bacterial cytoplasm to 
the eukaryotic cell using a pore at its end [113]. While the structure of the T3SS is 
conserved among Gram-negative bacteria, the effectors encoded differ from one 
another, subsequently to the intended host. In V. cholerae, the translocated effectors 
are multiple, and their accumulation disrupts host cellular processes with a key role 
in the early stages of infection, such as cytoskeletal rearrangement and cytotoxicity, 
resulting in intestinal epithelial damages and colonization of the gut [109, 114].
2.4.1 Structure and secretion through the T3SS
The T3SS is a multicomponent apparatus spawning both bacterial membranes. 
While the effectors’ secretion through T3SS is Sec independent, the translocation 
of the membrane components of the injectosome requires it [113]. The T3SS uses 
ATP for the active translocation of the effectors through both bacterial membranes 
directly into host cell cytoplasm. The T3SS consists of an injectosome with struc-
tural and genetic homology to the flagellum and a molecular syringe, the structure 
has been reviewed elsewhere [113]. In brief, the syringe connects the membrane 
complex to the host cell cytoplasm. It is composed of (i) a basal needle, (ii) a tip 
and, at its end, (iii) a translocation pore. The membrane complex is composed of an 
assembly of concentric rings creating a channel through both bacterial membranes. 
It includes an outer membrane ring connected, in the periplasm, to the inner 
membrane ring, in addition to a cytoplasmic portion, made of a cytoplasmic ring 
and an ATPase complex. The exact T3SS assembly in V. cholerae has not been studied 
yet, and some components remain to be identified [109].
2.4.2 Genes and regulation
While some Vibrio species (V. parahaemolyticus) possess two T3SS (T3SS1 and 
T3SS2), only one, with similarities to the T3SS2 of V. parahaemolyticus, has been 
found in V. cholerae’s genome [111]. The T3SS genes are located on a genomic island 
of approximatively 49kb, which includes an integrase, structural components, 
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effectors and regulators (vttRA, vttRB) [114]. The T3SS genomic island is acquired 
by horizontal transfer [115]. The core region contains most of the structural 
components and some effectors, while the upstream and downstream regions, 
more affected by the gene transfer, harbor a variety of effectors [109]. The Vibrio 
type three regulators VttRA and VttRB share similarities with ToxR, an important 
virulence regulator in V. cholerae [116]. The regulators VttRA and ToxR control the 
expression of VttRB, which, afterwards, controls the expression of the T3SS struc-
tural genes in presence of bile [117]. The deletion of either of these regulators leads 
to a decreased T3SS-dependant cytotoxicity. VttRA and VttRB might also regulate 
genes outside the T3SS island [110].
2.4.3 Secreted proteins
The presence of T3SS in non O1/O139 strains leads to intestinal epithelium 
damages, such as alteration of the brush border and disruption, as seen in the 
infant rabbit model of infection [112]. It is the result of the translocation of many 
effectors into the eukaryotic host cytoplasm by the T3SS. In V. cholerae, there are 
7 effectors encoded within the T3SS core genomic island and at least 5 others have 
been identified in the up and downstream regions [109]. The first effector to be 
identify is Vibrio outer protein F (VopF - NT01VC2350) [118, 119]. VopF pos-
sesses 2 actin binding domains, the formin homology-1 like and WASP homology 
2 domains, that intervene in actin polymerization of the host intestinal epithelial 
cells. It has been shown to be essential for virulence in infant mouse model of 
infection [119]. VopF has a homolog in other non O1/O139 strains, VopN, that 
shares 55% similarity [119]. Just like VopF, VopN disturbs actin polymerization by 
nucleation, but unlike VopF, locates in the stress fibers by binding filamin. Both 
would also have an anti-apoptotic effect.
A total of 11 proteins that use the T3SS for their secretion have been identified 
by using a FRET technique to visualize the translocation of proteins in HeLa cells, 
including an effector specific to V. cholerae, VopX (A33_1663) [114]. VopX has been 
found to be essential for colonization in infant mouse model of infection and to 
induce an important growth defect in S. cerevisiae by destabilization of the cell wall 
through Cell Wall Integrity MAP kinase pathway activation [114, 120].
Another of the secreted effectors is VopE (A33_1662) [121]. VopE is translocated 
to the mitochondria after its secretion by the T3SS, where it acts as a GTPase-
activating protein. Its presence in the mitochondria intervenes with the normal 
process of Rho GTPases Miro1 and 2, thus with the immune response using mito-
chondrial signalisation pathways [121, 122]. Along with VopF, VopE would lead to 
the loosening of the tight junctions, a primordial structure of the intestinal epithe-
lium [119]. VopM (A33_1684) is another effector secreted by the T3SS that leads to 
actin stress fibers formation and brush border effacement [110].
Other effectors have been identified, but their function remains unclear, such 
as VopZ (A33_1704), VopW (A33_1690), VopA (A33_1680), VopG (A33_1697), 
VopI (A33_1687), VopY (A33_1700), VopH (A33_1678) and VopK (A33_1699) 
[110, 114]. VopW is known as a hydrophilic translocator that would both have 
structural and effector roles [114]. Despite the lack of information, a study on 
multiple effectors brought some light on their potential role in infection [110]. 
It stated that VopA, VopM, VopW and VopH seemed to be required for intestinal 
colonization in infant mouse model of infection, as mutants of these effectors 
where not recovered from infected animals. VopA could also have a role in adhe-
sion to the intestinal cells in the early stages of infection. Along with VopH, VopI 




2.5 Type IV secretion system, a crucial virulence factor
Three T4Ps can be found at the surface of V. cholerae, TCP, the chitin regulated 
pilus (ChiRP) and the mannose sensitive hemagglutinin pilus (MSHA). T4P have 
structural similarities with the T2SS, and their structure has been reviewed else-
where [123]. An inner membrane complex, docking an ATPase cytoplasmic com-
plex, recruits a secretion pore in the outer membrane. The pilin subunits are then 
assembled and secreted to form a strong but malleable filament. They have a role in 
many biological processes leading to virulence such as, in V. cholerae, acquisition of 
mobile genetic elements (MGE), micro-colonies formation in the intestinal lumen, 
adhesion to abiotic surfaces or chitin and biofilm formation [123]. The bacterial 
aggregation by pilus-pilus interaction with TCP, in form of micro-colonies, allows 
concentration of the toxin at the site of colonization and protection of the immune 
system (as would a biofilm) [124]. Most T4Ps have cytoplasmic ATPases that allow 
their elongation and retraction, which can lead to eDNA capture and motility. The 
main secreted components of the T4P are the pilin subunits.
2.5.1 The toxin coregulated pilus
The pandemic virulence potential of V. cholerae resides in its MGE, harbouring 
both the CT and TCP apparel on the integrated CTXφ phage and Vibrio Pathogenic 
Island 1 (VPI-1), respectively [125]. TCP is essential for effective colonization of the 
intestinal epithelium in pandemic O1/O139 strains [126]. The VPI-1 harbours the 
receptor for the CTXφ phage, the major pilin of TCP (TcpA), allowing its entry into 
V. cholerae. It also regulates the CT production with ToxT, which also regulates TCP 
expression [48, 125]. It is believed that acquisition of both these MGE is enough to 
convert environmental strains into pathogenic strains [125]. Considering this infor-
mation, it is clear that the gene acquisition by horizontal transfer is important for the 
toxigenic potential of V. cholerae. Obviously, TcpA, being the major component of the 
filament, is responsible for the pilus:pilus interaction that leads to the formation of 
the micro-colonies [124]. TCP also has a minor pilin, TcpB, which is also secreted and 
initiates pilus polymerization and retraction, despite the lack of a retraction ATPase 
in TCP [127]. TcpB would also bind to CTXφ minor coat protein and then leads to its 
internalization into V. cholerae by initializing the retraction of the T4P [127].
2.5.2 The mannose sensitive hemagglutinin pilus
MSHA is produced by O1 El Tor and O139 strains, but not by the O1 classical 
strains, and is important for adhesion to chitinous surface and biofilm formation, 
although it does not seem to play a role in virulence nor colonization in humans [27, 
31, 126, 128]. Its filament is composed of the single major pilin MshA [129]. The 
dynamic of retraction/polymerization of the MSHA is controlled by c-di-GMP [129].
2.5.3 The chitin regulated pilus
The third T4P identified in V. cholerae is ChiRP [31]. Because, in its marine life, 
V. cholerae can use chitin as a carbon source, the capacity to colonize shellfish is then 
primordial to acquire this element. The expression of PilA, the major pilin of ChiRP, 
is induced when the bacteria are grown in presence of chitin [31]. The absence of 
PilA, thus of ChiRP, decreases, but does not suppress, the ability of V. cholerae to 
colonize crab shell, even though it has no effect in infant mouse model nor on adhe-
sion to human cells [130]. It suggests that ChiRP has a role in adhesion to chitin in 
collaboration with other chitin binding structures and proteins (MSHA, GbpA). The 
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colocalization of ChiRP at the pole of V. cholerae along with the T2SS, secreting chitin-
ases required for chitin acquisition, would increase the effectiveness of chitin uptake 
by limiting the secretion to an adhesion site [31]. In other Vibrio, ChiRP could also 
have a role in biofilm formation by mediating bacterium:bacterium interactions, a 
phenomenon that has also been observed in V. cholerae and that could further increase 
chitin uptake [131, 132]. It is important to note that the chitin utilization pathway is 
linked with natural competence pathway and that ChiRP is implied in eDNA uptake 
[131]. eDNA uptake is used by bacteria to gain new functions, such as virulence and 
resistance factors, and to increase their fitness and survival in environment.
2.6 Other secreted molecules
The cholix toxin (ChxA) is a eukaryotic elongation factor-2 specific ADP-
rybosyl transferase that induces cell death [133]. ChxA is produced by many  
V. cholerae strains [134, 135].
Accessory cholera enterotoxin (Ace - VC1459) and zonula occludens toxin 
(Zot - VC1458) are accessory toxins that are both encoded near the CT genes on the 
CTXφ phage [136, 137]. Zot leads to the disruption of the tight junctions between 
intestinal epithelial cells, an important structure in the intestinal permeability [138, 
139]. It is translocated and anchored in the outer membrane and has two functional 
domains. The N-terminal domain is important for CTXφ phage’s morphogenesis 
and the C-terminal domain is cleaved by proteases. Once released into the intes-
tinal lumen, the C-terminal domain acts as a toxin [139, 140]. Thus, Zot does not 
employ a conventional secretion system for its release into the extracellular milieu. 
Regarding Ace, it leads to fluid secretion in rabbit ileal loop model by unbalancing 
calcium secretion and the secretion mechanism has not been determined yet [138].
3. Membrane vesicles, the type 0 secretion system
Most bacteria, including Gram-negative and Gram-positive bacteria, release MV, 
also known as the type 0 secretion system [141]. Different types of MV can be pro-
duced including the outer membrane vesicles (OMV), the outer-inner membrane 
vesicles (OIMV), the cytoplasmic membrane vesicles (CMV) and the tube-shaped 
membranous structures (TSMS). The different types of MV differ in their com-
position and their biogenesis mechanisms, which will not be presented here since 
they have already been reviewed elsewhere [142]. V. cholerae can secrete OMV and 
OIMV, which contain lipopolysaccharides, phospholipids, proteins [143], DNA and 
RNA [144, 145]. An hypervesiculation has been reported in V. cholerae at the early 
stages of intestine colonization by silencing the phospholipid transporter VacJ/Yrb 
involved in the maintenance of the outer membrane lipid asymmetry. This hyperve-
siculation is characterized by a drastic modification of the membrane composition 
and a better colonization of the host intestine [146].
In vitro, the protein cargo of MV is highly dependent on the bacterial growth 
conditions [147]. The protein cargo of the MV secreted by V. cholerae El Tor O1 
has been determined under virulence activating conditions. A total of 90 proteins 
associated to MV have been identified, 50 % being outer membrane or periplasmic 
proteins [143]. Among these proteins, some are secreted in association with the 
vesicles, such as the membrane and periplasmic proteins, while others are secreted 
independently and associated with the vesicles in the extracellular compartment, 
such as Bap1 [148]. The proteins associated with the vesicles can have a role in 




3.1 Membrane vesicles and resistance
A role for the MV in antimicrobial peptides (AMP) resistance has been reported 
in several Gram-negative bacteria including V. cholerae. Our previous studies dem-
onstrated that PrtV-associated MV can protect V. cholerae from the lysis by LL-37, a 
cathelicidin secreted by the epithelial cells in response to V. cholerae infection [56]. 
In addition, the matrix protein Bap1 can bind to OmpT, a porin located in the outer 
membrane, on the surface of the MV of V. cholerae in presence of polymyxin B and 
confer cross-resistance to LL-37 [148]. Interestingly, the hypervesiculation observed 
during the early stages of infection leads to a decrease of OmpT in the outer mem-
brane correlated with an increase in OmpT abundance in the MV [146]. The authors 
suggest that the hypervesiculation is a process used by V. cholerae to quickly modify 
the outer membrane protein content in order to increase the intestinal colonization 
fitness. Therefore, the hypervesiculation in vivo may contribute to the Bap1 medi-
ated AMP resistance in the intestine where analogues of polymyxin B are secreted 
by the microbiota. In V. cholerae, the expression of ompT is negatively correlated 
with the expression of ompU through the ToxR switch [149, 150]. During the hyper-
vesiculation process, ompU expression increases, leading to an accumulation of 
OmpU in the membrane [148]. A role of OmpU in AMP and bile resistance has been 
reported in V. cholerae [151]. Therefore, the hypervesiculation in V. cholerae might 
represent a double advantage in terms of AMP resistance through vesicles associated 
OmpT-Bap1 and membrane bounded OmpU.
Besides AMP, MV are also involved in serum resistance in V. cholerae. Septicemia 
caused by V. cholerae has been reported, especially in patients suffering liver disor-
ders, which can lead to a 50% mortality rates [152]. In an elegant study, Aung et al. 
demonstrated that IgG present in the serum of healthy people can recognize OmpU 
of V. cholerae, which leads to the recruitment of the complement through C1q bind-
ing and to the clearance of V. cholerae [153]. However, the presence of OmpU in the 
MV can sequester the anti-OmpU IgG before they reach the bacterial cells, leading 
to an increased resistance of the bacteria to serum [153].
A role of the MV in resistance to bacteriophages has also been demonstrated 
in V. cholerae [154]. The authors proposed that, similarly to Bap1 and AMP and to 
OmpU and IgG, the presence of MV is used as bacterial decoy to lure the phages 
before they can reach the bacterial cell. In this case, it is the presence of phage 
receptors on the surface of the MV that is responsible for the sequestration of the 
phages [154].
3.2 Membrane vesicles and biofilm
A significant part of antimicrobial resistance is associated with the biofilm 
lifestyle of bacteria. The bacteria growing in a biofilm are up to 1000 times more 
resistant to antimicrobials and disinfectants than their planktonic counterparts 
[155]. It has been demonstrated that MV are involved in the formation of biofilms 
in several Gram-negative bacteria [156]. In V. cholerae, the association of Bap1, PrtV 
and eDNA with the MV might have a role in biofilm formation by strengthening the 
structure and by recruiting planktonic bacteria. More information on the role of 
MV in biofilm is provided in the Biofilms and Flagella section.
3.3 Membrane vesicles and virulence
The MV can also carry virulence factors including the CT, the major virulence 
factor of V. cholerae [157]. After secretion, The B subunits interact with the GM1 
receptor at the surface of the epithelial cells and the toxin is endocytosed. The A 
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subunit dissociates from the rest of the toxin in the endoplasmic reticulum and 
spontaneously unfold. The unfolded form of the A subunit is responsible for the 
toxic activity of the CT. The vesicle-associated toxin is biologically active although 
only A subunits are encapsulated [158]. It has been demonstrated that the MV can 
enter inside the host cells using different mechanisms involving clathrin coated pits, 
formation of caveolae, use of lipid rafts and direct fusion with host cell membrane 
[159]. Therefore, it is likely that the lack of B subunits is not an issue for the delivery 
of active A subunits of the CT while encapsulated inside the MV.
Besides the CT, other biologically active virulence factors can also be transported 
to the host cells through MV. It is the case for HA/P and VesC [160], PrtV metal-
loprotease [56] and the VCC [161]. Therefore, the MV of V. cholerae can carry a 
concentrated arsenal of virulence factors that can be efficiently delivered to the host 
cells and have a role in V. cholerae pathogenesis.
4. Biofilms and flagella
Most of the bacteria, including pathogens, form biofilm to survive and persist 
in different environments. Biofilms are organized bacterial communities attached 
to a surface and producing a matrix. V. cholerae form biofilms at different stages of 
its life cycle. An increasing number of evidences suggest that V. cholerae forms bio-
film during the gut infection and biofilm-like aggregates display a hyper-infective 
phenotype [162]. To persist in the environment, V. cholerae forms biofilm on dif-
ferent biotic and abiotic substrates such as floating aggregates, ship hulls, microal-
gae and copepods [163]. The transition between planktonic motile and non-motile 
biofilm states is highly regulated [162, 164]. The composition and abundance of 
the secreted factors involved in biofilm formation, maturation and dispersion 
largely depend on environmental conditions and on surface composition. In this 
section, we will review the current knowledge about the biofilm secretome in 
V. cholerae at different stages of the biofilm formation and the interplay between 
biofilm and motility.
4.1 From motility to initial adhesion
Planktonic V. cholerae are motile cells and their motility is ensured by a single 
polar flagellum. The flagellum is composed of three major structural compo-
nents: i) the basal body, ii) the hook and iii) the filament (for detailed structure: 
[165]). Structurally, the flagellum is closely related to the T3SS and therefore 
has been referred as fT3SS (flagellum Type-3 Secretion System) [166]. The main 
proteins secreted through the fT3SS are the flagellins. In V. cholerae, five dif-
ferent flagellins (FlaA-E) encoded on two chromosomally distinct loci (flaAC 
and flaEDB) have been described. From these 5 flagellins, only FlaA is essential 
for the motility [167]. Recently, an elegant study from Dongre and coll. demon-
strated that the cytotoxin MakA is also secreted through the fT3SS [168]. This 
toxin is involved in colonization and virulence in zebrafish and C. elegans infec-
tion models and represents the first characterization of a toxin secreted through 
the fT3SS in V. cholerae [168].
V. cholerae motility and chemotaxis are important for the virulence in the human 
gut [169]. They are necessary for the bacteria to travel from the lumen to the epithe-
lial cells, where the virulence factors are secreted after attachment of the bacteria. 
Motility also plays a key role in biofilm formation on surfaces as an essential element 
of the initial adhesion of the bacteria. On abiotic surfaces, V. cholerae’s adhesion 
involves MSHA to “scan the surface” [170]. The flagellum is responsible for the 
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bacterial rotation on the surface of the support, which allows MSHA to reach a spot 
of high affinity. This adhesion is signaled through the flagellum rotor and results in 
an inhibition of motility pathways and the secretion of the Vibrio polysaccharides 
(VPS) [171]. Two other T4Ps are implicated in bacterial adhesion; ChiRP and TCP 
(see T4SS section). Initial adhesion to biotic surface is promoted by GbpA, which is 
secreted through the T2SS and induces mucin secretion [21].
Additionally, FrhA (hemagglutinin) and CraA (adhesin) secreted through 
the T1SS are involved in adhesion and biofilm formation (see T1SS section). The 
expression of both frhA and craA is controlled by a c-di-GMP-dependent regulatory 
system [108]. In addition, frhA is regulated by the flagella regulation pathways, 
reinforcing the role of flagella in the initial stages of biofilm formation [106].
4.2 Biofilm maturation
Once attached, Vibrio starts secreting VPS, which represent more than 50% of 
matrix composition. VPS polymers are secreted throughout the biofilm production 
and are mostly composed of [→4)-α-L-GulpNAcAGly3OAc-(1→4)-β-D-Glcp-
(1→4)-α-d-Glcp-(1→4)-α-D-Galp-(1→] subunits. A variant representing around 
20% of VPS consists on the same pattern except for the α-D-Glcp moiety that 
is replaced by α-D-GlcpNAc [172]. The VPS biogenesis and export systems are 
encoded on two clusters: VpsI and VpsII, encoding VpsA-K and VpsL-Q, respec-
tively [173, 174]. Among the 18 vps genes, 15 of them induced highly impaired 
biofilm formation in V. cholerae when suppressed [174]. Recently, a model has 
been proposed for the production and secretion of VPS. In this model, the VPS are 
synthesized by formation and polymerization of individual subunits. The poly-
mers are then transferred across the outer membrane through VpsM/N [175]. This 
system is tightly controlled by the tyrosine phosphoregulatory system VpsO/VpsU, 
which controls the level of phosphorylation of the C-terminal tyrosine-cluster of 
VpsO. High level of phosphorylation results in VpsO oligomer dissociation and VPS 
production reduction, whereas low level of VpsO phosphorylation results in high 
oligomerization and increased VPS production [175].
Shortly after VPS secretion has been initiated, the sequential secretion of the 3 
major biofilm matrix proteins through the T2SS occurs. The first matrix protein to 
be secreted is RbmA, followed by Bap1 and RbmC [176]. More specifically, RmbC 
has a role in maintaining and stabilizing the biofilm [177]. A study using mutants 
lacking RbmC and its homolog Bap1 showed a change of colonial morphology and 
the loss of biofilm formation capacity [177, 178]. On the other hand, RbmA controls 
the structure of the biofilm [9, 179].
Growth of the biofilm is ensured by two different processes: (i) the bacteria 
inside the matrix are dividing inside an envelope formed by the VPS, RbmC and 
Bap1 [176] and (ii) new bacteria are recruited inside the biofilm. This recruitment 
requires the cleavage of the N-terminal domain of RbmA by PrtV. Once cleaved, 
RbmA can bind bacterial cells that are not producing VPS (planktonic) and recruits 
them into the biofilm [180]. Since MV have been observed in the biofilm matrix 
and PrtV can be associated to the surface of the MV, it is possible that MV play an 
important role in biofilm maturation in V. cholerae [181]. In addition, the association 
of Bap1 to the MV in specific conditions is likely to lead to the adhesion of the MV to 
the surface and to the exopolysaccharides [181]. Three other proteins with no role in 
biofilm formation and adhesion have been identified in biofilm preparation, i.e. the 
hemolysin HylA, HA/P and ChiA-2 [182].
Besides VPS, proteins and MV, a significant amount of eDNA is entrapped in 
the biofilm matrix. The roles of eDNA in bacterial physiology have been reviewed 
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elsewhere and include nutrient source, horizontal gene transfer and adherence 
[183]. Recently, a role in the tridimensional matrix structure of the biofilm in  
V. cholerae has been reported [184]. The eDNA inside the biofilm most probably 
results from cell autolysis and MV secretion [185].
4.3 Biofilm dispersion and detachment
Biofilm dispersal is a complex process by which bacteria actively succeed to 
evade biofilm matrix [186]. Conversely to adhesion and biofilm maturation, little 
is known about the dispersion process of V. cholerae biofilms. It requires specific 
environmental signals, which trigger the quorum sensing and the general stress 
response pathways [187], matrix degradation and motility resumption [188]. The 
matrix degradation requires RbmB, an extracellular polysaccharide lyase that 
digests the VPS, and LapG, a periplasmic protease that cleaves the adhesins FrhA 
and CraA located at the outer membrane [188]. Under substrate specific conditions, 
the extracellular protease HA/P also participates in biofilm dispersion by degrad-
ing the mucin [189]. Finally, secreted nucleases such as Dns and Xds have a role in 
biofilm dispersion by cleaving the eDNA present in the matrix [185]. The motility 
resumption requires the ability to switch the flagella rotation from counterclock-
wise to clockwise direction mediated by CheY3 independently of chemotaxis [188].
5. Conclusion
Over the last decades, numerous studies have focused on the secreted molecules 
and secretion systems used by V. cholerae to deliver extracellular effectors. Various 
roles have been assigned to the secreted molecules especially regarding the host 
colonization and virulence, and the environmental survival and persistence, 
denoting their importance in V. cholerae’s pathogenesis and life cycle. Additionally, 
the redundancy of some functions carried by multiple secreted effectors testi-
fies of their importance. With gene acquisition, MGE, strain sequencing and the 
emergence of more efficient technologies, it is most likely that additional secreted 
effectors and secretion systems will be identified and characterized.
The recent characterization of the MakA toxin secretion through the fT3SS [168] 
and the numerous studies on the T6SS since its discovery 15 years ago [68] clearly 
demonstrate that there is still work to do on the secretome and secretion systems in 
V. cholerae. The secretion mechanism of some extracellular proteins - with charac-
terized functions - remains to be determined. It is the case of ChxA, Ace, RbmB and 
the DNAse Dns.
The regulation of the secretion systems and their cargo molecules is a complex 
process. It involves numerous regulators that can be activated or repressed depend-
ing on the detection of specific intracellular and extracellular signals. So far, most of 
the studies aiming to decipher the regulation pathways have been performed under 
laboratory conditions. The featuring of conditions that characterize the intestinal 
environment before and during diarrhea, including the peristaltic movement, 
anaerobia, the presence of the microbiota, water efflux and high osmolarity, is 
likely to modify V. cholerae secretion in terms of regulation and nature, abundance 
and activity of the secreted molecules. Therefore, it would be highly beneficial to 
study the secretion mechanisms, the secreted molecules and their regulation in 
models that are closer to the physiological conditions encountered in the host, such 
as ex vivo devices. Understanding the regulation and the mechanisms of coloniza-
tion, virulence and resistance in these physiological conditions is crucial for the 
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